Klotho Neurosciences Inc

Insider buying spurs optimism at Klotho Neurosciences, as executives acquire millions of shares amid the company’s pivot from biotech to critical‑minerals mining, potentially unlocking new growth and shareholder value.

Insider buying signals Klotho’s pivot to critical‑mineral mining—CEO’s 350k share grant shows confidence, hinting at new revenue streams and upside potential for investors.

Insider buys 350k Klotho shares as company pivots from neuro‑therapeutics to mining assets, boosting investor confidence in its new growth strategy.